Company Profile
Nutriband Stock Price, News & Analysis
- Ticker:
- NTRB
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
2.92 USD (+1.22%)
Close
Last updated: August 6, 2026
43.2M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, NTRB closed up 1.22% at $2.92. No new same-company headline was identified in the current news window.
Company overview
Business overview
Nutriband is a specialty drug-delivery company focused on transdermal technologies and abuse-deterrent patch platforms. Its story is centered on formulation science and the possibility of licensing or commercializing delivery systems for regulated products.
Geographic Base and Sector Classification
Nutriband is headquartered in the United States and listed on NASDAQ, with a small-cap specialty drug-delivery profile. It sits in the pharmaceutical technology niche rather than broad biotech.
Business Model Characteristics
The business depends on product development, regulatory progress, and partner interest in the delivery platform. Investors typically watch licensing, formulation updates, and the company's ability to create value from a narrow technology base.
Position Within the Biotechnology Landscape
Nutriband occupies a niche position in drug delivery and abuse-deterrent formulation. It is more of a platform story than a classic therapeutics stock.
Future catalysts
Nutriband’s catalysts are Aversa-related transdermal abuse-deterrent development and any regulatory step that keeps the platform credible. The company still needs a practical commercialization path.
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Nutriband (NTRB)?
Nutriband (NTRB) most recently closed at 2.92 USD, a +1.22% move versus the previous session.
What is the market cap of Nutriband (NTRB)?
Nutriband currently has a market capitalization of 43.2M USD on BioPharmSignal.
What does Nutriband do?
Nutriband is a specialty drug-delivery company focused on transdermal technologies and abuse-deterrent patch platforms. Its story is centered on formulation science and the possibility of licensing or commercializing delivery systems for regulated products.
On which exchange is NTRB stock listed?
Nutriband (NTRB) is associated with NASDAQ, United States, Biopharma.
What is Nutriband?
Nutriband’s catalysts are Aversa-related transdermal abuse-deterrent development and any regulatory step that keeps the platform credible.
Which conditions is Nutriband targeting with Nutriband?
Nutriband’s catalysts are Aversa-related transdermal abuse-deterrent development and any regulatory step that keeps the platform credible.
How does Nutriband describe recent progress with Nutriband?
Nutriband’s catalysts are Aversa-related transdermal abuse-deterrent development and any regulatory step that keeps the platform credible.
What is Aversa-related?
Nutriband’s catalysts are Aversa-related transdermal abuse-deterrent development and any regulatory step that keeps the platform credible.